JPH01256587A - Antioxidant composition - Google Patents
Antioxidant compositionInfo
- Publication number
- JPH01256587A JPH01256587A JP63084669A JP8466988A JPH01256587A JP H01256587 A JPH01256587 A JP H01256587A JP 63084669 A JP63084669 A JP 63084669A JP 8466988 A JP8466988 A JP 8466988A JP H01256587 A JPH01256587 A JP H01256587A
- Authority
- JP
- Japan
- Prior art keywords
- mulberry
- vitamin
- bark extract
- prevent
- antioxidant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003078 antioxidant effect Effects 0.000 title claims description 22
- 239000000203 mixture Substances 0.000 title claims description 17
- 239000003963 antioxidant agent Substances 0.000 title claims description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 33
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 20
- 240000000249 Morus alba Species 0.000 claims abstract description 20
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 16
- 239000011709 vitamin E Substances 0.000 claims abstract description 16
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 16
- 229940046009 vitamin E Drugs 0.000 claims abstract description 16
- 235000006708 antioxidants Nutrition 0.000 claims description 15
- 239000000047 product Substances 0.000 abstract description 15
- 239000002537 cosmetic Substances 0.000 abstract description 8
- 238000000605 extraction Methods 0.000 abstract description 6
- 230000003647 oxidation Effects 0.000 abstract description 5
- 238000007254 oxidation reaction Methods 0.000 abstract description 5
- 239000004094 surface-active agent Substances 0.000 abstract description 5
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 abstract description 4
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 abstract description 4
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 abstract description 4
- 239000002076 α-tocopherol Substances 0.000 abstract description 3
- 235000004835 α-tocopherol Nutrition 0.000 abstract description 3
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 abstract description 2
- 239000007799 cork Substances 0.000 abstract description 2
- 235000010389 delta-tocopherol Nutrition 0.000 abstract description 2
- 230000006866 deterioration Effects 0.000 abstract description 2
- 239000012467 final product Substances 0.000 abstract description 2
- 235000010382 gamma-tocopherol Nutrition 0.000 abstract description 2
- 239000011590 β-tocopherol Substances 0.000 abstract description 2
- 235000007680 β-tocopherol Nutrition 0.000 abstract description 2
- 239000002478 γ-tocopherol Substances 0.000 abstract description 2
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 abstract description 2
- 239000002446 δ-tocopherol Substances 0.000 abstract description 2
- 241000218231 Moraceae Species 0.000 abstract 1
- 244000293610 Morus bombycis Species 0.000 abstract 1
- 235000006721 Morus bombycis Nutrition 0.000 abstract 1
- 239000008278 cosmetic cream Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000002978 peroxides Chemical class 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- -1 gallic acid ester Chemical class 0.000 description 4
- 239000004006 olive oil Substances 0.000 description 4
- 235000008390 olive oil Nutrition 0.000 description 4
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 2
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 2
- 235000019489 Almond oil Nutrition 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008168 almond oil Substances 0.000 description 2
- 229940087168 alpha tocopherol Drugs 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 235000021081 unsaturated fats Nutrition 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- WCVOGSZTONGSQY-UHFFFAOYSA-N 2,4,6-trichloroanisole Chemical compound COC1=C(Cl)C=C(Cl)C=C1Cl WCVOGSZTONGSQY-UHFFFAOYSA-N 0.000 description 1
- BVCOHOSEBKQIQD-UHFFFAOYSA-N 2-tert-butyl-6-methoxyphenol Chemical compound COC1=CC=CC(C(C)(C)C)=C1O BVCOHOSEBKQIQD-UHFFFAOYSA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N anhydrous gallic acid Natural products OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- QYDYPVFESGNLHU-UHFFFAOYSA-N elaidic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCC(=O)OC QYDYPVFESGNLHU-UHFFFAOYSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- QYDYPVFESGNLHU-KHPPLWFESA-N methyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC QYDYPVFESGNLHU-KHPPLWFESA-N 0.000 description 1
- 229940073769 methyl oleate Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は酸化防止剤組成物に関し、更に詳しくは皮膚外
用製品に好適で、抗酸化性の向上を目的としたビタミン
Eと桑白皮エキスとを含有する酸化防止剤組成物に関す
る。[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to an antioxidant composition, more specifically, it is suitable for external skin products and contains vitamin E and mulberry bark extract for the purpose of improving antioxidant properties. and an antioxidant composition containing the same.
[従来の技術]
一般に不飽和系油脂や界面活性剤は紫外線または空気中
の酸素等によって酸化を受は易く、その結果変色や変臭
を生じることが知られており、従ってそれら成分を含む
製品には酸散を防ぐために通常酸化防止剤を配合するこ
とが多い。[Prior Art] In general, unsaturated fats and oils and surfactants are known to be easily oxidized by ultraviolet rays or oxygen in the air, resulting in discoloration and odor. Therefore, products containing these ingredients are Usually, antioxidants are added to prevent acid dispersion.
また近年、過酸化物は皮膚に対して有害となり、化粧品
のような皮膚外用製品に過酸化物が含まれているとその
使用で皮膚のかぶれやかゆみ、さらに黒皮症や肝斑等の
疾病を引き起こすおそれがあることも報じられている。In addition, in recent years, peroxide has become harmful to the skin, and if peroxide is included in external skin products such as cosmetics, the use of peroxide can cause skin irritation and itching, as well as diseases such as melasma and melasma. It has also been reported that it may cause
そこで製品中の酸化による過酸化物の生成を防止する上
で酸化防止剤の果たす役割は重要となり、積極的に配合
検討がなされると同時に油脂や界面活性剤等の構成成分
面での選択も必要とされてきた。Therefore, the role of antioxidants in preventing the formation of peroxides due to oxidation in products is important, and at the same time active consideration is being given to formulations, selection of components such as oils and fats and surfactants is also being carried out. has been needed.
従来、かくした酸化防止剤としては、ビタミンE、 2
,4−ジーtert−ブチルーP−クレゾール、ter
t−ブチルヒドロキシアニソール、没食子酸エステル等
が代表的なものとして挙げられ、使用されてきた。Conventionally, such antioxidants include vitamin E, 2
, 4-di-tert-butyl-P-cresol, ter
Typical examples include t-butylhydroxyanisole and gallic acid ester, which have been used.
[発明が解決しようとする課題]
しかしながら、前記した従来公知の酸化防止剤は、酸化
防止を期待して使用されているが所期の目的達成にとフ
てほとんど効果が得られず、また多量に用いるにしても
配合面での制約から充分な効果が得難い、或いは皮膚安
全性面で好ましくないといったものかあって必ずしも満
足し得るところでなかった。[Problems to be Solved by the Invention] However, although the conventionally known antioxidants described above are used with the expectation of preventing oxidation, they have little effect in achieving the intended purpose, and they are used in large amounts. Even when used for this purpose, it has not always been satisfactory because it is difficult to obtain a sufficient effect due to restrictions in formulation, or it is unfavorable in terms of skin safety.
その上現状として、製品の酸化防止ばかりでなく、皮膚
表面でも常に皮表脂質から過酸化脂質が生成され、過酸
化脂質の蛋白変性作用や老化との係り合い等も示されて
おり、従って製品由来であれ、皮表脂質由来であれ、過
酸化物を可能な限り排除することが望ましく、酸化防止
効果を一層高め、過酸化物による皮膚障害を予防するこ
とが大切な問題となってきている。Furthermore, the current situation is that not only does the product prevent oxidation, but lipid peroxide is constantly generated on the skin surface from skin surface lipids, and it has been shown that lipid peroxide has a protein denaturing effect and is related to aging. It is desirable to eliminate peroxides as much as possible, regardless of whether they are derived from peroxides or from skin surface lipids, and it is becoming important to further enhance the antioxidant effect and prevent skin damage caused by peroxides. .
[課題を解決するための手段]
本発明者等は、前記した事情に鑑み、従来に増して抗酸
化性をより一層向上させるべく鋭意検討を重ねた結果、
ビタミンEと桑白皮エキスとを併用することにより、過
酸化物の生成を有効に抑制でき、顕著な酸化防止効果が
得られることを見い出し、この知見をもって本発明を完
成させたのである。[Means for Solving the Problems] In view of the above-mentioned circumstances, the present inventors have conducted extensive studies to further improve the antioxidant properties, and as a result,
It was discovered that by using vitamin E and mulberry bark extract in combination, the production of peroxides can be effectively suppressed and a remarkable antioxidant effect can be obtained, and the present invention was completed based on this knowledge.
すなわち本発明は、ビタミンEと桑白皮エキスとを含有
してなる酸化防止剤組成物に関するものである。That is, the present invention relates to an antioxidant composition containing vitamin E and mulberry bark extract.
以下本発明の構成について説明する。The configuration of the present invention will be explained below.
本発明で使用されるビタミンEとしては、天然ビタミン
E、α−トコフェロール、β−トコフェロール、γ−ト
コフェロール、δ−トコフェロール等であり、これらの
一種または二種以上を適宜選択して用いることができる
。The vitamin E used in the present invention includes natural vitamin E, α-tocopherol, β-tocopherol, γ-tocopherol, δ-tocopherol, etc., and one or more of these can be appropriately selected and used. .
また本発明での桑白皮エキスとは、クワ科(Morac
eae)のクワ、カラクワ0jorus alba L
、)、ヤマグワ(M、 bombycis KOID7
.、)、マグワ (M。In addition, the mulberry bark extract in the present invention refers to the mulberry bark extract used in the present invention.
eae)'s mulberry, Karakwa 0 jorus alba L
), Yamaguwa (M, bombycis KOID7
.. ), Magwa (M.
1atifolia POIRET、)などの根皮のコ
ルク層を除゛去したものから抽出して得られるものであ
る。It is obtained by extracting from the root bark of plants such as 1atifolia POIRET, from which the cork layer has been removed.
抽出方法は特に限定しないが、例えば抽出溶媒として、
水、メチルアルコール・エチルアルコール等の低級−価
アルコール、プロピレングリコール・ 1.3−ブチレ
ングリコール等の液状多価アルコール、酢酸エチルエス
テル等の低級アルキルエステル、ベンゼン・ヘキサン等
の炭化水素、エチルエーテル等が挙げられ、こわらの一
種、または二種以上を組み合わせて使用し得る。これら
の抽出溶媒と共に室温又は加温して抽出し、濾過して得
られる抽出液、またはこれを濃縮したものが用いられる
。The extraction method is not particularly limited, but for example, as an extraction solvent,
Water, lower alcohols such as methyl alcohol and ethyl alcohol, liquid polyhydric alcohols such as propylene glycol and 1,3-butylene glycol, lower alkyl esters such as ethyl acetate, hydrocarbons such as benzene and hexane, ethyl ether, etc. One type of stiff straw or a combination of two or more types can be used. An extract obtained by extraction with these extraction solvents at room temperature or with heating and filtration, or a concentrated product thereof is used.
本発明におけるビタミンEと桑白皮エキスの酸化防止剤
組成物としての使用量は、最終製品の全量あたり、ビタ
ミンEの場合、0.0001〜5.0重量%、桑白皮エ
キスの場合、固形分として0.0001〜3.0重量%
の範囲であり、この範囲であれば酸化防止効果を期待す
る効果的な添加量として好ましく、充分量である。そし
てこれらは目的に応じて最適組成比を随時設定し、配合
することで用いられる。In the present invention, the amount of vitamin E and mulberry bark extract used as an antioxidant composition is 0.0001 to 5.0% by weight in the case of vitamin E, and 0.0001 to 5.0% by weight in the case of mulberry bark extract, based on the total amount of the final product. 0.0001-3.0% by weight as solid content
This range is a preferable and sufficient amount as an effective addition amount to expect an antioxidant effect. These are used by setting and blending the optimum composition ratio according to the purpose.
本発明の酸化防止剤組成物は、酸化を受は易いオリーブ
油、ホホバ油、アーモンド油、スクワレン等の不飽和系
油脂、モノオレイン酸グリセリン、セスキオレイン酸ソ
ルビタン、トリオレイン酸ポリオキシエチレンソルビタ
ン等の不飽和系界面活性剤またこれらを含む製品に対し
て使用することにより、抗酸化性面での安定性を図るこ
とができる。The antioxidant composition of the present invention contains unsaturated fats and oils that are easily oxidized such as olive oil, jojoba oil, almond oil, squalene, glyceryl monooleate, sorbitan sesquioleate, polyoxyethylene sorbitan trioleate, etc. By using unsaturated surfactants or products containing these, stability in terms of antioxidant properties can be achieved.
そして本発明の酸化防止剤組成物としての使用は、化粧
品等の皮膚外用製品に好適である。The antioxidant composition of the present invention is suitable for use in external skin products such as cosmetics.
化粧品としては例えば、ローション、乳液、クリーム、
ペースト状の皮膚化粧料をはじめ、洗顔料、パック料、
メーキャップ化粧料、頭髪・頭皮用製品、口唇用製品、
爪用製品等での利用に適するものであり、これら製品に
抗酸化安定性を付与できるので極めて有用である。Examples of cosmetics include lotions, milky lotions, creams,
Including paste skin cosmetics, facial cleansers, packs,
Makeup cosmetics, hair and scalp products, lip products,
It is suitable for use in nail products and the like, and is extremely useful as it can impart antioxidant stability to these products.
[実施例]
次に、本発明について、実施例を挙げてさらに説明する
。これらは本発明を何ら限定するものでない。[Example] Next, the present invention will be further explained by giving examples. These do not limit the invention in any way.
実施例 [+1
本発明の効果を確認するために表1に示す試料、■〜■
の5種を用い、自動酸化に対する安定性試験を行った。Example [+1] Samples shown in Table 1 to confirm the effects of the present invention, ■~■
A stability test against autooxidation was conducted using 5 types.
試験方法は、基準油脂分析試験法(日本油化学協会)の
AOM試験に準じ、油浴の温度は 97.8℃に、空気
流量は2.3ml/secに設定し、5.5時間後に各
試料のPOVを測定することにより行った。結果は表1
に示す。尚、表中のデータは試験を3回実施した測定結
果の平均値で表わした。The test method was based on the AOM test of the Standard Oil and Fat Analysis Test Method (Japan Oil Chemists Association), the oil bath temperature was set at 97.8°C, the air flow rate was set at 2.3 ml/sec, and each This was done by measuring the POV of the sample. The results are in Table 1
Shown below. Note that the data in the table is expressed as the average value of the measurement results obtained by conducting the test three times.
表 1
表1の結果に認められるように、dl−α−トコフェロ
ールと桑白皮エキスを併用した場合(試料■〜■)は、
それぞれを単独で用いた場合(試料■〜■)と比較し、
povが低く、オレイン酸メチルに対して過酸化物の生
成が有効に抑制され、酸化防止効果が顕著に発揮される
ことが明らかになり、酸化防止剤として極めて有用であ
ることが判る。Table 1 As seen in the results in Table 1, when dl-α-tocopherol and mulberry bark extract were used together (samples ■ to ■),
Compared to when each was used alone (samples ■ to ■),
It has been revealed that the pov is low, that the production of peroxides is effectively suppressed relative to methyl oleate, and that the antioxidant effect is significantly exhibited, indicating that it is extremely useful as an antioxidant.
実施例 [21
表2に示す試料、■〜■の4種を用い、実施例[11と
同様にしてPOvを測定した。結果は表2に示す。尚、
表中のデータは試験を2回実施した測定結果の平均値で
表した。Example [21] POv was measured in the same manner as in Example [11] using the four samples shown in Table 2, ■ to ■. The results are shown in Table 2. still,
The data in the table is expressed as the average value of the measurement results obtained by conducting the test twice.
表 2
表2の結果に認められるように、天然ビタミンEと桑白
皮エキスを併用した場合(試料■)は、それぞれを単独
で用いた場合(試料■〜■)と比較してPOVが著しく
低く、顕著な酸化防止効果を有することが明らかになっ
た。Table 2 As seen in the results in Table 2, when natural vitamin E and mulberry bark extract were used together (Sample ■), the POV was significantly higher than when each was used alone (Samples ■ to ■). It was revealed that the antioxidant effect was low and significant.
実施例 [3]クリーム
(処方) (重量%)(11オ
リーブ油 5.0(2) アー
モンド油 10.0(3)ステアリ
ルアルコール 3.0(4) モノオレイン
酸グリセリン 1.5(5) セスキオレイン酸
ソルビタン 0.5(6) モノオレイン酸ポリ
オキシエ 1.0チレンソルビタン(20E、O,
)
(7)グリセリン 7.0(8)
α−トコフェロール 0.1(9)桑白
皮工、キス(エチルアル 5.0コール抽出)
00) ヒアルロン酸 0.0
1(10香料 0.20
2)バラオキシ安息香酸メチル 0.103)精
製水 残量(製法)
成分(1)〜(四を混合し、加熱溶解する。これを別に
混合、加熱溶解した成分(6)〜03)に徐々に添加し
て乳化を行ない、冷却してクリームを得た。Example [3] Cream (prescription) (% by weight) (11 Olive oil 5.0 (2) Almond oil 10.0 (3) Stearyl alcohol 3.0 (4) Glyceryl monooleate 1.5 (5) Sesquiolein Acid sorbitan 0.5 (6) Monooleate polyoxye 1.0 tyrene sorbitan (20E, O,
) (7) Glycerin 7.0 (8)
α-tocopherol 0.1 (9) Mulberry bark, kiss (ethyl alcohol 5.0 col extraction) 00) Hyaluronic acid 0.0
1 (10 fragrance 0.20
2) Methyl roseoxybenzoate 0.103) Purified water Remaining amount (manufacturing method) Mix components (1) to (4) and heat and dissolve. Gradually add this to components (6) to 03 that were mixed separately and heated and dissolved. The mixture was added to emulsify and cooled to obtain cream.
実施例 [4] パウダーファンデーション(処方)
(重量%)(1) 酸化
チタン l010(2) カオリ
ン 25.0(3) タルク
40.0(4) ベンガラ
0.8(5) 黄酸化鉄
2.5(6)黒酸化鉄
0.1(7)マイカ
残量(8) オリーブ油
7.0(9) セスキオレイン酸ソルビタン
1.000)グリセリン 3
.0(ロ)天然ビタミンE O,0
502)2−ヒドロキシ−4−メトキシ o、iベン
ゾフェノン
03) エス力ロール507 1.0(
14) 桑白皮エキス(l、3−ブチ 0.ル
ンゲリコール抽出)
05) 香料 0.1(
+6) パラオキシ安息香酸メチル 0.05
(製法)
成分(1)〜(7)を混合し、粉砕して均質にする。Example [4] Powder foundation (formulation)
(Weight%) (1) Titanium oxide 1010 (2) Kaolin 25.0 (3) Talc 40.0 (4) Red iron oxide 0.8 (5) Yellow iron oxide 2.5 (6) Black iron oxide
0.1(7) Mica
Remaining amount (8) Olive oil
7.0(9) Sorbitan sesquioleate 1.000) Glycerin 3
.. 0 (b) Natural vitamin E O,0
502) 2-Hydroxy-4-methoxy o,i benzophenone 03) S-Ryki Roll 507 1.0 (
14) Mulberry bark extract (l, 3-buty 0. rungericol extract) 05) Fragrance 0.1 (
+6) Methyl paraoxybenzoate 0.05
(Manufacturing method) Components (1) to (7) are mixed and pulverized to make it homogeneous.
これに予め混合、加熱溶解した成分(8)〜(+6)を
加え、均一に混合した後、粉砕し、次いでプレス成型し
てパウダーファンデ・−ジョンを得た。Components (8) to (+6) previously mixed and heated and dissolved were added thereto, mixed uniformly, pulverized, and then press-molded to obtain a powder foundation John.
実施例[5] ビールオフ型パック
(処方) (重量%)(1)
酢酸ビニル樹脂エマルジョン 15.0(り ポ
リビニルアルコール l000(3) オリ
ーブ油 3.0(4) 天然ビタ
ミンE O,1(均 セスキオレイ
ン酸ソルビタン 0.5((へ)桑白皮エキス(水
抽出)1.0(7) デオキシリポ核酸ナトリウム
0.01(8)酸化チタン
8.0(9) カオリン 7
.000) エチルアルコール 5.
0(II) 香料 o、
102)精製水 残量(製法
)
成分(匂〜(5)、00)を混合後、成分(+2)を加
え、加熱溶解する。次いでこれに成分(6)〜(9)、
(ロ)を加えて混合し、冷却した後、成分C1)を添加
、混合してビールオフ型パックを得た。Example [5] Beer-off type pack (formulation) (wt%) (1)
Vinyl acetate resin emulsion 15.0 (ri) Polyvinyl alcohol 1000 (3) Olive oil 3.0 (4) Natural vitamin E O,1 (uniform) Sorbitan sesquioleate 0.5 ((f) Mulberry bark extract (water extraction) 1 .0(7) Sodium deoxyliponucleic acid
0.01(8) Titanium oxide
8.0(9) Kaolin 7
.. 000) Ethyl alcohol 5.
0(II) Fragrance o,
102) Purified water Remaining amount (manufacturing method) After mixing the components (odor ~ (5), 00), add the component (+2) and dissolve by heating. Next, components (6) to (9) are added to this,
After adding and mixing (b) and cooling, component C1) was added and mixed to obtain a beer-off type pack.
[発明の効果]
゛ 以上詳述した如く、本発明はビタミンEと桑白皮エ
キスとを含有することにより、これら成分の酸化防止効
果が発揮された酸化防止剤組成物を提供するものである
。[Effects of the Invention] As detailed above, the present invention provides an antioxidant composition that contains vitamin E and mulberry bark extract and exhibits the antioxidant effects of these components. .
すなわち本発明により、従来に増して顕著な酸化防止効
果を有するものであって、不飽和系油脂や界面活性剤の
酸化を防止し、化粧品等の製品の劣化防止が可能である
と共に、過酸化物の生成を効果的に抑制できることから
化粧品等に添加し、適用した際に過酸化物の皮膚に対す
る悪影響の防止が期待でき、さらには製品に配合して利
用することにおいて安定性、安全性がよく、極めて有用
な酸化防止剤組成物が得られたのである。In other words, the present invention has a more remarkable antioxidant effect than ever before, and can prevent the oxidation of unsaturated oils and surfactants, prevent deterioration of products such as cosmetics, and prevent peroxidation. Because it can effectively suppress the formation of peroxides, it can be expected to prevent the harmful effects of peroxide on the skin when added to cosmetics, etc., and further improve stability and safety when used in products. Well, a very useful antioxidant composition has been obtained.
以 上 出願人 株式会社 小林コーセーthat's all Applicant: Kobayashi Kose Co., Ltd.
Claims (1)
を特徴とする酸化防止剤組成物。(1) An antioxidant composition containing vitamin E and mulberry bark extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63084669A JP2799569B2 (en) | 1988-04-06 | 1988-04-06 | Antioxidant composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63084669A JP2799569B2 (en) | 1988-04-06 | 1988-04-06 | Antioxidant composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01256587A true JPH01256587A (en) | 1989-10-13 |
JP2799569B2 JP2799569B2 (en) | 1998-09-17 |
Family
ID=13837120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63084669A Expired - Lifetime JP2799569B2 (en) | 1988-04-06 | 1988-04-06 | Antioxidant composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2799569B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2673530A1 (en) * | 1991-03-06 | 1992-09-11 | Moreau Monique | Anti-free-radical and anti-malonaldehyde extracts of mulberry leaves |
JP2004359732A (en) * | 2003-06-02 | 2004-12-24 | Ryukyu Bio Resource Kaihatsu:Kk | Antioxidant |
US7285294B2 (en) | 2000-12-22 | 2007-10-23 | Shiseido Company, Ltd. | Hair growth inhibitors and composition containing same |
EP2092837A1 (en) | 2008-02-25 | 2009-08-26 | Inha-Industry Partnership Institute | Compositions for skin whitening comprising (2Z, 8Z) - matricaria acid methyl ester |
CN108261346A (en) * | 2018-03-01 | 2018-07-10 | 森知(上海)国际贸易有限公司 | A kind of lightening compositions and preparation method thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021119664A1 (en) | 2019-12-10 | 2021-06-17 | Mary Kay Inc. | Herbal cosmetic composition for treating skin |
-
1988
- 1988-04-06 JP JP63084669A patent/JP2799569B2/en not_active Expired - Lifetime
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2673530A1 (en) * | 1991-03-06 | 1992-09-11 | Moreau Monique | Anti-free-radical and anti-malonaldehyde extracts of mulberry leaves |
US7285294B2 (en) | 2000-12-22 | 2007-10-23 | Shiseido Company, Ltd. | Hair growth inhibitors and composition containing same |
JP2004359732A (en) * | 2003-06-02 | 2004-12-24 | Ryukyu Bio Resource Kaihatsu:Kk | Antioxidant |
EP2092837A1 (en) | 2008-02-25 | 2009-08-26 | Inha-Industry Partnership Institute | Compositions for skin whitening comprising (2Z, 8Z) - matricaria acid methyl ester |
CN108261346A (en) * | 2018-03-01 | 2018-07-10 | 森知(上海)国际贸易有限公司 | A kind of lightening compositions and preparation method thereof |
CN108261346B (en) * | 2018-03-01 | 2020-12-29 | 上海科颜生物科技有限公司 | Whitening composition and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
JP2799569B2 (en) | 1998-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH05271048A (en) | Cosmetics and pharmaceutical composition | |
JPS6127910A (en) | Cosmetic | |
JPH01256587A (en) | Antioxidant composition | |
JPH0881325A (en) | Cosmetic | |
JP2799568B2 (en) | Antioxidant composition | |
JP2676049B2 (en) | Skin cosmetics | |
JP4073539B2 (en) | Cosmetics | |
JPS63254181A (en) | Antioxidant composition | |
CN114828839A (en) | Vitamin A and vitamin C combinations with enhanced stability | |
JPH04288009A (en) | Oxidation preventive system and composition containing same | |
JPH11199463A (en) | Skin cosmetic | |
JPH01149706A (en) | Skin-beautifying cosmetic | |
JP4124318B2 (en) | Antioxidants and external preparations for skin | |
JPS63254180A (en) | Antioxidant composition | |
JP2006282536A (en) | Super oxide-eliminating agent, free radical-eliminating agent, hydrogen peroxide-eliminating agent and external preparation for skin | |
EP0445735A1 (en) | Melanogenesis-inhibiting endermic preparation | |
JP2019131524A (en) | Cosmetic and skin external preparation | |
JP2000327570A (en) | Skin preparation for external use | |
KR20130028480A (en) | Cosmetic composition comprising weighting agent | |
JP4836986B2 (en) | Antioxidants and external preparations for skin | |
JP7051494B2 (en) | Cosmetics and external skin preparations | |
JP4309190B2 (en) | Topical skin preparation | |
JPH0899821A (en) | Skin external agent | |
JPH0358326B2 (en) | ||
KR20230124686A (en) | A cosmetic care or perfume composition in a two-phase form |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070710 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080710 Year of fee payment: 10 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080710 Year of fee payment: 10 |